ESC 365 - Smokeless tobacco, snus, at admission for percutaneous coronary intervention and future risk of death

ESC Premium Access

Smokeless tobacco, snus, at admission for percutaneous coronary intervention and future risk of death

Session: Poster Session 7 - Coronary artery disease - Diagnosis, pharmacotherapy and revascularisation

Topic: Revascularisation

Speaker: Doctor P. Andell (Stockholm, SE)

Event: ESC Congress 2018

Congress Presentation

About the speaker

Doctor Pontus Andell

Karolinska University Hospital, Stockholm (Sweden)

0 follower

16 more presentations in this session

Fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Accelerated versus standard Streptokinase infusion regimen; a randomized clinical study

Speaker: Associate Professor A. Bendary (Benha, EG)

Heart rate reduction with ivabradine restores endothelial function and reduces vascular stiffness in patients with chronic stable coronary artery disease

Speaker: Doctor A. Hohneck (Mannheim, DE)

Comparative efficacy of angiotensin converting enzyme inhibitor and angiotensin receptor blocker for patients with acute myocardial infarction and renal dysfunction

Speaker: Doctor J. Won (Gwangju, KR)

Therapeutic advantages of long-acting trimetazidine for the treatment of stable angina pectoris in routine clinical practice: findings from ODA trial

Speaker: Professor M. Glezer (Moscow, RU)

Mid-term outcomes of second-generation drug-eluting-stent implantation for left main coronary artery disease compare with first-generation drug-eluting-stent

Speaker: Doctor G. Yoshioka (Saga, JP)

Access the full session

Poster Session 7 - Coronary artery disease - Diagnosis, pharmacotherapy and revascularisation

Speakers: Doctor P. Andell, Associate Professor A. Bendary, Doctor A. Hohneck, Doctor J. Won, Professor M. Glezer...

About the event

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by